SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50...
Hence then, the article about innovative immunology biotech windward bio lists on nasdaq was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Innovative Immunology Biotech Windward Bio Lists on Nasdaq )
Also on site :
- Aspen Dental Opens in Willis With Comprehensive Care, Emergency Appointments and App-Based Scheduling
- Le Dahua Pro Challenge 2026 célèbre l'expertise des installateurs du monde entier et la collaboration à long terme
- THG LABS Selects Centric PLM to Connect Beauty Innovation From Formulation to Commercialization